The Veteran's immune thrombocytopenia has been rated as noncompensable since August 19, 2021. The Board found that the disability is fully capable of evaluation under the rating schedule and does not warrant a higher rating.
The deciding factor: The Veteran's platelet count was between 91,000 and 157,000 throughout the appeal period, which did not meet the criteria for any higher ratings based on the revised VA Schedule for Rating Disabilities (Rating Schedule).
- Claimed conditions
- immune thrombocytopenia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 0%
- Decision date
- October 28, 2024
- Citation
- A24069042
Veterans Law Judge
Decisions by this judge: 1,044 · Granted: 21% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24069042.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's service-connected disabilities, including his back and knee conditions and psychiatric disorder, prevent him from securing or maintaining gainful employment. The Board has granted a TDIU based on the combined rating of at least 70 percent.
- Granted
The Board has granted the Veteran's claim for service connection for a blood disorder, variously diagnosed as Acute Myeloid leukemia, B-cell lymphoproliferative disorder, and immune thrombocytopenia. The Board found that exposure to toxic chemicals and smoke during service is at least in equipoise with his current blood disorders.
- Remanded (sent back)
The Veteran's immune thrombocytopenia is currently rated at 70 percent, effective August 16, 2019. The appeal is remanded as the symptoms do not more nearly approximate chronic refractory thrombocytopenia requiring chemotherapy or a platelet count of 30,000 or below despite treatment.
- Remanded (sent back)
The Veteran's TTP is being remanded for additional development, including obtaining private treatment records and an updated VA examination to assess the current severity of his disability.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.